Acciones Peloton Therapeutics, Inc.
Acciones
PLTX
US70614L1044
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,29 % | 114 mil M | |
+10,21 % | 104 mil M | |
-11,90 % | 22,41 mil M | |
+0,23 % | 22,28 mil M | |
-5,61 % | 19,07 mil M | |
-37,36 % | 18 mil M | |
-5,17 % | 17,89 mil M | |
+7,70 % | 14,28 mil M | |
+37,65 % | 12,55 mil M |